
89bio, Inc.
89bio, Inc. (ETNB) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
etnb · stock forecast · 15 analysts (3M) · FMP · updated Feb 6, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$25.00
Consensus
$17.17
+15.7% upside
Low
$12.00
Median: $14.5 · Last Close: $14.84
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$17.17
15.7% upside
High Target
$25
68.5%
Low Target
$12
-19.1%
Current Price
$14.84
as of today
Based on analyst price targets, the ETNB stock price prediction for the next 12 months ranges from $12 to $25. The consensus ETNB price forecast of $17.17 implies 15.7% upside from the current price of $14.84.
Short-Term Price Prediction
RangingAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $14.83 | ↓ 0.09% |
1-day model range: $14.82–$14.83. Peak: $14.83 (-0.09%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ETNB · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-09-19 | Raymond James | Downgrade ↓ | Outperform→Market Perform |
| 2025-09-19 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-09-19 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2025-08-25 | B of A Securities | Maintains | Buy→Buy |
| 2025-08-08 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-31 | UBS | Maintains | Buy→Buy |
| 2025-01-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-02 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on 89bio, Inc. (ETNB) stock. Of the recent 89 rating actions, 2 were upgrades and 6 were downgrades. 15 analysts currently cover ETNB.
Analyst Recommendation Trends
ETNB analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3M
↓ 90.9% YoY
Revenue Next Year
$4M
↑ 22.4% YoY
EPS This Year
$-2.21
EPS Next Year
$-2.30
↑ 4.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ETNB EPS of $-2.21 for the current fiscal year, based on estimates from 5 analysts. The ETNB revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ETNB stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ETNB price target is $17.17 (+15.7% upside), with an analyst consensus of Buy.
The ETNB short-term stock prediction for tomorrow is $14.83 (-0.09%).
89bio, Inc. trades on NASDAQ under the ticker ETNB. The ETNB stock outlook for 2027 is broadly positive, supported by a Buy consensus among 60% of covering analysts.
Frequently asked questions
ETNB forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month ETNB price target is $17.17, with a high forecast of $25.00 and a low of $12.00. The median price target is shown in the chart above when available. This implies +15.7% potential upside from the current price of $14.84.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.